AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2024
Feb 23, 2024
35221_dirs_2024-02-23_b09dcf8d-c051-4b6b-8966-336f95e55698.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2024-02-22
Reporting Person: Baxter Timothy E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-22 | Common stock | A | 65000 | — | Acquired | 65000 | Direct |
Footnotes
F1: The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan.
More from PAVmed Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Jan 23